Videos

The director of the neurology residency training program at the Icahn School of Medicine at Mount Sinai addresses the challenges of approving cannabinoid products in the US.

Episode 3 of the AUPN Leadership Minute features Rohit Das, MD, of University of Texas Southwestern Medical Center at Dallas; and Mehmood Rashid, MD, of University of Toledo. [WATCH TIME: 4 minutes]

The professor from the Universite de Sherbrooke discusses how his recent study supports the concept of brain energy rescue.

The director of the Montefiore Einstein Center for the Aging Brain discussed the advantages of non-invasive brain stimulation and what has been previously observed in patients with Alzheimer disease.

Neurology News Network for the week ending November 14, 2020.

The executive VP and chief research officer of MDA also discussed future plans on making MOVR and its platform accessible to centers outside of the MDA network.

The chief scientific officer of the Parkinson’s Foundation discussed what has previously been observed in genetic Parkinson disease and what gaps the PD GENEration initiative may fill.

The executive VP and chief research officer of MDA spoke about how the new visualization reporting platform will also allow for easy recruitment of data to be used in future clinical trials and research studies.

The professor of neurology at the NYU Langone Grossman School of Medicine outlined the confusion on whether deaths are related to COVID-19, a symptom associated, or previously unidentified underlying condition.

The professor of clinical neurology at University of Miami and MT2020+ chair discussed the initiative’s effort to improve the global accessibility of mechanical thrombectomy.

The professor of clinical neurology at University of Miami and MT2020+ chair discussed the initiative’s effort to improve the global accessibility of mechanical thrombectomy.

The director of Translational Research and Clinical Trials Epilepsy at NYU Grossman School of Medicine discussed the need to improve education about nonmotor seizures.

The vascular neurologist at Memorial Hermann Medical Group discusses how stroke care has been affected throughout the COVID-19 pandemic.

The director of Translational Research and Clinical Trials Epilepsy at NYU Grossman School of Medicine discussed the groundwork done with the Human Epilepsy Project for a recent analysis.

The Cleveland Clinic researcher discussed the unknowns about Parkinson disease dementia and what has been previously observed in clinical studies.

The associate professor of neurology at Washington University in St. Louis detailed a number of key presentations on advances and novel medications in the sleep space.